107 related articles for article (PubMed ID: 2810910)
1. [Evaluation of serum pepsinogen I and II of patients with gastric cancer].
Kimura Y; Fujii T; Hamamoto K; Miyagawa N; Tsuda K; Tanada S; Iio A
Kaku Igaku; 1989 Sep; 26(9):1127-33. PubMed ID: 2810910
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein.
Chung HW; Kim JW; Lee JH; Song SY; Chung JB; Kwon OH; Lim JB
J Clin Gastroenterol; 2009 Jan; 43(1):19-26. PubMed ID: 18648315
[TBL] [Abstract][Full Text] [Related]
4. [A case of a gastric cancer patient with high serum pepsinogen levels at relapse].
Kimura Y; Fujii T; Miyagawa N; Tanada S; Hamamoto K; Kimura S
Gan No Rinsho; 1990 Jul; 36(8):945-8. PubMed ID: 2366328
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
Aoki K; Misumi J; Kimura T; Zhao W; Xie T
J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
[TBL] [Abstract][Full Text] [Related]
6. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
7. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
[TBL] [Abstract][Full Text] [Related]
8. [Distribution of serum pepsinogen I, II values and their ratios in residents of a rural area].
Aoki K; Misumi J
Nihon Koshu Eisei Zasshi; 1993 Apr; 40(4):313-22. PubMed ID: 8329751
[TBL] [Abstract][Full Text] [Related]
9. Serum pepsinogens I and II and stomach cancer.
Stemmermann GN; Samloff IM; Nomura AM; Heilbrun LK
Clin Chim Acta; 1987 Mar; 163(2):191-8. PubMed ID: 3568423
[TBL] [Abstract][Full Text] [Related]
10. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of serum pepsinogen levels in patients with gastric-carcinoma.
Maeda K; Chung Y; Onoda N; Nisimura S; Nitta A; Arimoto Y; Kato Y; Sowa M
Int J Oncol; 1993 Sep; 3(3):437-40. PubMed ID: 21573383
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative determinations of pepsinogen I in gastric cancer and premalignant changes of the stomach.
Westerveld BD; Pals G; Défize J; Pronk J; Frants RR; Kreuning J; Eriksson AW; Meuwissen SG
Prog Clin Biol Res; 1985; 173():201-12. PubMed ID: 3885251
[TBL] [Abstract][Full Text] [Related]
14. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
15. Serum pepsinogen I levels in relation to pepsinogen phenotypes.
Pals G; Biemond I; Défize J; Westerveld BD; Pronk JC; Meuwissen SG; Eriksson AW
Prog Clin Biol Res; 1985; 173():91-100. PubMed ID: 3983199
[TBL] [Abstract][Full Text] [Related]
16. Using serum pepsinogens wisely in a clinical practice.
Miki K; Urita Y
J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
[TBL] [Abstract][Full Text] [Related]
17. The relation of serum pepsinogen to gastric cancer and its precursors in Hawaii Japanese men: a progress report.
Stemmermann GN; Heilbrun LK; Nomura A; Samloff IM
Prog Clin Biol Res; 1985; 173():213-20. PubMed ID: 3983194
[TBL] [Abstract][Full Text] [Related]
18. [Comparative examinations of serum pepsinogen I, II and gastric area using computed radiography in the atrophic gastritis].
Tatsu Y; Ogura Y; Yamazaki K; Nobuhara M; Ishimaru T; Matsui R; Shimizu T; Takeuchi M; Sueyoshi K; Narabayashi I
Kaku Igaku; 1995 Nov; 32(11):1259-62. PubMed ID: 8558795
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of serum pepsinogen levels for prediction of recurrence in gastric carcinoma].
Maeda K; Chung YS; Onoda N; Nishimura S; Nitta A; Arimoto Y; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2079-81. PubMed ID: 8215486
[No Abstract] [Full Text] [Related]
20. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens.
Hattori Y; Tashiro H; Kawamoto T; Kodama Y
Jpn J Cancer Res; 1995 Dec; 86(12):1210-5. PubMed ID: 8636012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]